Cargando…

Fatty acid binding protein 7 may be a marker and therapeutic targets in clear cell renal cell carcinoma

BACKGROUND: To identify potential therapeutic target in clear cell renal cell carcinoma (ccRCC), we performed a transcriptome analysis. Our analysis showed that fatty acid binding protein 7 (FABP7) has the highest mean differential overexpression in ccRCC compared to normal kidney. We aimed to inves...

Descripción completa

Detalles Bibliográficos
Autores principales:	Nagao, Kazuhiro, Shinohara, Nachi, Smit, Frank, de Weijert, Mirjam, Jannink, Sander, Owada, Yuji, Mulders, Peter, Oosterwijk, Egbert, Matsuyama, Hideyasu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2018
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6238291/ https://www.ncbi.nlm.nih.gov/pubmed/30442117 http://dx.doi.org/10.1186/s12885-018-5060-8

Ejemplares similares

Combination of sunitinib and (177)Lu-labeled antibody cG250 targeted radioimmunotherapy: A promising new therapeutic strategy for patients with advanced renal cell cancer
por: Oosterwijk-Wakka, Jeannette C., et al.
Publicado: (2022)

Successful Combination of Sunitinib and Girentuximab in Two Renal Cell Carcinoma Animal Models: A Rationale for Combination Treatment of Patients with Advanced RCC
por: Oosterwijk-Wakka, Jeannette C., et al.
Publicado: (2015)

Molecular Profiling of Druggable Targets in Clear Cell Renal Cell Carcinoma Through Targeted RNA Sequencing
por: van den Heuvel, Corina N. A. M., et al.
Publicado: (2019)

Application of Monoclonal Antibody G250 Recognizing Carbonic Anhydrase IX in Renal Cell Carcinoma
por: Oosterwijk-Wakka, Jeannette C., et al.
Publicado: (2013)

Clinical significance of programmed death‐1 and programmed death‐ligand 1 expression in the tumor microenvironment of clear cell renal cell carcinoma
por: Mikami, Shuji, et al.
Publicado: (2019)

Follow-up imaging after cryoablation of clear cell renal cell carcinoma is feasible using single photon emission computed tomography with (111)In-girentuximab
por: van Oostenbrugge, Tim J., et al.
Publicado: (2019)

Tumor-targeted Dual-modality Imaging to Improve Intraoperative Visualization of Clear Cell Renal Cell Carcinoma: A First in Man Study
por: Hekman, Marlène C., et al.
Publicado: (2018)

Extracellular miR-224 as a prognostic marker for clear cell renal cell carcinoma
por: Fujii, Nakanori, et al.
Publicado: (2017)

A case of primary clear cell hepatocellular carcinoma comprised mostly of clear cells
por: Kokubo, Reiji, et al.
Publicado: (2019)

Antibody therapy in renal cell carcinoma
por: Oosterwijk, Egbert, et al.
Publicado: (2008)

Radiolabeled antibodies in renal cell carcinoma
por: Stillebroer, Alexander B., et al.
Publicado: (2007)

Zoledronic acid combined with androgen-deprivation therapy may prolong time to castration-resistant prostate cancer in hormone-naïve metastatic prostate cancer patients – A propensity scoring approach
por: Nagao, Kazuhiro, et al.
Publicado: (2016)

Inhibition of Fatty Acid Synthase Decreases Expression of Stemness Markers in Glioma Stem Cells
por: Yasumoto, Yuki, et al.
Publicado: (2016)

Clear Cell Adenocarcinoma of the Ureter Similar to Clear Cell Renal Cell Carcinoma Histology
por: Watanabe, Kazuhiro, et al.
Publicado: (2021)

Fatty Acid Binding Protein 7 is Involved in the Proliferation of Reactive Astrocytes, but not in Cell Migration and Polarity
por: Hara, Tomonori, et al.
Publicado: (2020)

Experimental rat bladder urothelial cell carcinoma models
por: Arentsen, Harm C., et al.
Publicado: (2009)

Phase I study to assess safety, biodistribution and radiation dosimetry for (89)Zr-girentuximab in patients with renal cell carcinoma
por: Merkx, Robin I. J., et al.
Publicado: (2021)

Risk stratification by means of biological age-related factors better predicts cancer-specific survival than chronological age in patients with upper tract urothelial carcinoma: a multi-institutional database study
por: Inamoto, Teruo, et al.
Publicado: (2018)

Serum Adiponectin Level May be an Independent Predictor of Clear Cell Renal Cell Carcinoma
por: Wang, Hongkai, et al.
Publicado: (2016)

Klinefelter syndrome: From pediatrics to geriatrics
por: Shiraishi, Koji, et al.
Publicado: (2018)

The effect of a cyclic uniaxial strain on urinary bladder cells
por: Tiemessen, Dorien, et al.
Publicado: (2017)

A case of clear cell renal cell carcinoma with vena cava thrombus responding to presurgical avelumab, and axitinib
por: Suzuki, Issei, et al.
Publicado: (2021)

Real-world efficacy and safety of two doses of cabazitaxel (20 or 25 mg/m(2)) in patients with castration-resistant prostate cancer: results of a Japanese post-marketing surveillance study
por: Matsuyama, Hideyasu, et al.
Publicado: (2020)

Safety and efficacy of cabazitaxel in 660 patients with metastatic castration-resistant prostate cancer in real-world settings: results of a Japanese post-marketing surveillance study
por: Suzuki, Kazuhiro, et al.
Publicado: (2019)

Real-world effectiveness of third-line cabazitaxel in patients with metastatic castration-resistant prostate cancer: CARD-like analysis of data from a post-marketing surveillance in Japan
por: Matsuyama, Hideyasu, et al.
Publicado: (2023)

Exogenous polyserine and polyleucine are toxic to recipient cells
por: Owada, Ryuji, et al.
Publicado: (2022)

IQGAP3 May Serve as a Promising Biomarker in Clear Cell Renal Cell Carcinoma
por: Meng, Quan, et al.
Publicado: (2021)

Four methylation‐driven genes may be prognostic biomarkers in clear cell renal carcinoma
por: Yin, Hang, et al.
Publicado: (2020)

The systemic inflammation-based Glasgow Prognostic Score as a powerful prognostic factor in patients with upper tract urothelial carcinoma
por: Inamoto, Teruo, et al.
Publicado: (2017)

Bone tumor–targeted delivery of theranostic (195m)Pt-bisphosphonate complexes promotes killing of metastatic tumor cells
por: Nadar, R.A., et al.
Publicado: (2020)

A Fatty Acid Metabolism Signature Associated With Clinical Therapy in Clear Cell Renal Cell Carcinoma
por: Wei, Zhihao, et al.
Publicado: (2022)

Isolation of multipotent progenitor cells from pleura and pericardium for tracheal tissue engineering purposes
por: de Wit, Rayna, et al.
Publicado: (2021)

Glycogen Rich Clear Cell Carcinoma (GRCC) of the breast may not have a poor prognosis
por: Baslaim, Muna M., et al.
Publicado: (2017)

Clinicopathological correlations of endometrioid and clear cell carcinomas in the uterus and ovary
por: Mori, Hidemi, et al.
Publicado: (2023)

A Potential Fatty Acid Metabolism-Related Gene Signature for Prognosis in Clear Cell Renal Cell Carcinoma
por: Zhang, He, et al.
Publicado: (2022)

Comprehensive analysis of the associations between clinical factors and outcomes by machine learning, using post marketing surveillance data of cabazitaxel in patients with castration-resistant prostate cancer
por: Kazama, Hirotaka, et al.
Publicado: (2022)

Recurrence prediction in clear cell renal cell carcinoma using machine learning of quantitative nuclear features
por: Matsubara, Shuya, et al.
Publicado: (2023)

Fatty acid metabolism-related signature predicts survival in patients with clear cell renal carcinoma
por: Wang, Rongjiang, et al.
Publicado: (2022)

Clearing up Clear Cell: Clarifying the Immuno-Oncology Treatment Landscape for Metastatic Clear Cell RCC
por: Doppalapudi, Sai Krishnaraya, et al.
Publicado: (2021)

Non-diethylstilbestrol exposed vaginal clear cell adenocarcinoma has a common molecular profile with ovarian clear cell adenocarcinoma: A case report
por: Ikeda, Yuji, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_4cummbbc7nkebf2t4g2294p7u1